More News

29 Feb 2020 Biogen and Sangamo Announce Global Collaboration to Develop Gene Regulation Therapies for Alzheimer’s, Parkinson’s, Neuromuscular, and Other Neurological Diseases
26 Feb 2020 Arcus Biosciences and Taiho Pharmaceutical Co., Ltd. Jointly Announce Taiho’s Exercise of Its Option for an Exclusive License to Zimberelimab (AB122) for Its Territories in Japan and Other Asian Countries
26 Feb 2020 Takeda Acquires PvP Biologics Following Results of a Phase 1 Study of TAK-062 (Kuma062) for the Treatment of Celiac Disease
25 Feb 2020 Peptilogics Announces CARB-X Funding to Accelerate Development of First-in-Class Antibiotics to Address the Global Threat of Multi-drug Resistant Bacteria
25 Feb 2020 Bicycle Therapeutics Announces Exclusive Strategic Collaboration with Genentech to Develop and Commercialize Bicycle®-based Immuno-oncology Therapies
24 Feb 2020 Sanofi to create new industry leading European company to provide active pharmaceutical ingredients (API*)
20 Feb 2020 Tocagen and Forte Biosciences Announce Merger
20 Feb 2020 Caribou Biosciences and ProMab Biotechnologies Announce Sale and Assignment Agreement for Humanized scFv Targeting BCMA
20 Feb 2020 Five Prime Therapeutics Licenses Antibodies to Seattle Genetics for Use in Novel Antibody Drug Conjugate (ADC) Programs
19 Feb 2020 Nimble Announces Collaboration with Genentech to Discover and Develop Novel Peptide-Based Therapeutics
12 Feb 2020 OSE Immunotherapeutics Announces Artificial Intelligence Antibody Drug Development Collaboration with MAbSilico
10 Feb 2020 Blue Water Vaccines Licenses Patent Rights for Streptococcus Pneumoniae Vaccine Development from St. Jude Children's Research Hospital
06 Feb 2020 Atreca Announces Strategic Research Collaboration with Merck to Identify Novel Antibody Targets in Oncology
05 Feb 2020 Aimmune Licenses Exclusive Worldwide Rights to Xencor’s XmAb®7195 for the Development of Next-Generation Food Allergy Treatments
04 Feb 2020 SIRION Biotech Licenses Adenovirus Technology to Danish Startup, InProTher for its Novel Immunotherapy Design Targeting Endogenous Retrovirus (ERV)
04 Feb 2020 EyePoint Pharmaceuticals Signs Exclusive License Agreement with Equinox Science to Develop Tyrosine Kinase Inhibitor Vorolanib for the Treatment of Wet AMD, Diabetic Retinopathy and Retinal Vein Occlusion
03 Feb 2020 AgeX Therapeutics to Collaborate with University of California, Irvine on Neural Stem Cell Research Program for Huntington’s Disease and Other Neurological Disorders
03 Feb 2020 IMIDomics and Gossamer Bio Enter into a Strategic Collaboration to Advance the Development of Novel Treatments for Patients with Immune-Mediated Inflammatory Diseases
29 Jan 2020 Conatus Pharmaceuticals and Histogen Enter into Definitive Merger Agreement
28 Jan 2020 Syndivia In-Licenses DARx Technology for 1-to-1 Linkage of Antibodies and Payloads for Preparation of New Classes of Biologics
22 Jan 2020 Ocuphire Pharma Announces In-License of Phase 2 Oral Small Molecule Drug Candidate for Diabetic Retinopathy and Diabetic Macular Edema from Apexian Pharmaceuticals
21 Jan 2020 Ncardia and BlueRock Therapeutics Announce Collaboration Agreement and Licensing of Process Development Technologies for the Manufacture of iPSC-derived Cardiomyocytes
21 Jan 2020 PhoreMost enters multi-project drug discovery collaboration with Otsuka Pharmaceutical
17 Jan 2020 Syndivia In-Licenses Novel Antibody Against Tumor-Specific Form of CD146 From SATT Sud-Est
17 Jan 2020 BioNTech to acquire Neon to strengthen global leadership position in T cell therapies

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up